References
- Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–967.
- Coppolino G, Cernaro V, Placida G, et al. Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement. Cmc. 2018;25:4545–4551.
- Calcaterra F, Taddeo A, Colombo E, et al. Reduction of maternal circulating endothelial progenitor cells in human pregnancies with intrauterine growth restriction. Placenta 2014;35:431–436.
- Buemi M, Bolignano D, Barilla A, et al. Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. J Nephrol. 2008;21:663–672.
- Penno G, Pucci L, Lucchesi D, et al. Circulating endothelial progenitor cells in women with gestational alterations of glucose tolerance. Diab Vasc Dis Res. 2011;8:202–210.
- Dincer UD. Fetal exposure to a diabetic intrauterine environment resulted in a failure of cord blood endothelial progenitor cell adaptation against chronic hypoxia. Stem Cells Clon. 2015;8:1–14.
- Metsuyanim S, Harari-Steinberg O, Buzhor E, et al. Expression of stem cell markers in the human fetal kidney. PLOS One. 2009;4:e6709.
- Giordano D, Loddo S, Laganà AS, et al. Peripheral blood CD34(+) cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis. J Matern Fetal Neonatal Med. 2018;31:258–260.
- Szereday L, Miko E, Meggyes M, et al. Commitment of decidual haematopoietic progenitor cells in first trimester pregnancy. Am J Reprod Immunol. 2012;67:9–16.
- Uchimura H, Marumo T, Takase O, et al. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol. 2005;16:997–1004.
- Imasawa T, Utsunomiya Y, Kawamura T, et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol. 2001;12:1401–1409.
- Coppolino G, Bolignano D, Campo S, et al. Circulating progenitor cells after cold pressor test in hypertensive and uremic patients. Hypertens Res. 2008;31:717–724.
- Bolignano D, Coppolino G, Crascì E, et al. Pregnancy in uremic patients: an eventful journey. J Obstet Gynaecol Res. 2008;34:137–143.
- Coppolino G, Buemi A, Bolignano D, et al. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. J Surg Res. 2009;157:e129–e135.
- Buemi M, Allegra A, D’Anna R, et al. Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol. 2007;196:68.e1–68.e6.
- Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide. 2000;4:441–458.
- Brodowski L, Burlakov J, Hass S, et al. Impaired functional capacity of fetal endothelial cells in preeclampsia. PLoS One. 2017;12:e0178340.
- Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370–1376.
- Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–1457.